Squarepoint Ops LLC

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1642575 NEW YORK, NY

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,250,663

+$2,391,803 QoQ

Shares Held

176,955

+303.0% QoQ

Ownership

0.156%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#68

of 215 holders

Holding Since

Mar 2021

11 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. VRDN ranks #59 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,250,663	176,955	+303.0%	Shares	Defined	2026-08-14
2026-03-31	$858,860	43,909	-55.8%	Shares	Defined	2026-05-15
2025-03-31	$1,339,534	99,372	+198.9%	Shares	Defined	2025-08-27
2024-12-31	$637,421	33,251	-23.7%	Shares	Defined	2025-02-14
2024-09-30	$991,422	43,579	-69.5%	Shares	Defined	2024-11-14
2024-06-30	$1,859,597	142,936	+430.3%	Shares	Defined	2024-08-14
2024-03-31	$471,999	26,956	+156.3%	Shares	Defined	2024-05-15
2023-09-30	$161,361	10,519	-38.9%	Shares	Defined	2023-11-14
2022-12-31	$502,616	17,207	-72.0%	Shares	Defined	2023-02-14
2022-03-31	$1,135,101	61,390	+426.1%	Shares	Defined	2022-05-16
2021-03-31	$194,972	11,668	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.